# The Effects of Tegaserod vs. Placebo on Whole Gut Transit Time in Patients With Chronic Constipation and Dyspepsia

> **NCT00277550** · PHASE4 · WITHDRAWN · sponsor: **Novartis**

## Conditions studied

- Constipation and Dyspepsia

## Interventions

- **DRUG:** Tegaserod and Placebo

## Key facts

- **NCT ID:** NCT00277550
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2016-03-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00277550

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00277550, "The Effects of Tegaserod vs. Placebo on Whole Gut Transit Time in Patients With Chronic Constipation and Dyspepsia". Retrieved via AI Analytics 2026-08-17 from https://api.ai-analytics.org/clinical/NCT00277550. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*